Drug Profile
Research programme: anti-CCR5 monoclonal antibodies - Roche
Alternative Names: ROAb 12; ROAb 13; ROAb 14; ROAb 18Latest Information Update: 20 Aug 2008
Price :
$50
*
At a glance
- Originator Roche
- Class Monoclonal antibodies
- Mechanism of Action CCR5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 11 Jul 2008 Discontinued - Preclinical for HIV-1 infections in Germany (unspecified route)
- 11 Jul 2008 Discontinued - Preclinical for HIV-1 infections in USA (unspecified route)
- 16 Oct 2006 Preclinical trials in HIV-1 infections in Germany (unspecified route)